@FiercePharma: Shire's Vyvanse tops $1B as more generics challenge Adderall. Report | Follow @FiercePharma
@EricPFierce: Mylan currently the focus of a hot rumor for picking up the sterile injectables unit of India's Strides Arcolab. News | Follow @EricPFierce
@AlisonBFierce: A promising new vaccine--administered as a nasal spray--is shrinking head and neck tumors. More | Follow @AlisonBFierce
> The FDA has come out with a plan for approving generic drugs even when the drug they are copying is in the midst of a label change. Story
> New spin-off AbbVie ($ABBV) says it will buy back $1.5 billion in shares over the next couple of years. News
> A federal court has upheld two patents held by Cephalon, which is now owned by Teva ($TEVA), related to the cancer drug Fentora, turning back a generic challenge by Actavis ($ACT). Report
> After years of appeals, Sanofi ($SNY) has won a tax case in India that tried to nail it for capital gains taxes when it acquired Shantha in 2009. Article
@FierceMedDev: Cohera snags $17M to support TissuGlu. News | Follow @FierceMedDev
@MarkHFierce: Weight loss devices never go out of style. BAROnova secured a $27.3M Series C for its contribution to the space. More | Follow @MarkHFierce
@DamianFierce: St. Jude is studying whether renal denervation can treat heart attack and stroke in addition to hypertension. Press release | Follow @DamianFierce
> Acquisitions help boost Alere's 2012 Q4 revenue. Item
> J&J braces international market for more metal hip problems. Article
> Second Sight scores victory with FDA nod for retinal prosthesis. News
Biotech News
@FierceBiotech: Still trending: The 25 most influential people in biopharma today - 2013. Special Report | Follow @FierceBiotech
@JohnCFierce: Mega-mergers are back (expect 1-2 big deals in biopharma this year). News | Follow @JohnCFierce
@RyanMFierce: Japan takes lead in trialing a human stem cell therapy. Story | Follow @RyanMFierce
> GSK's Slaoui talks up 'innovative' late-stage pipeline as regulatory reviews loom. Article
> Biotech benefits from 'breakthrough' guess for its cancer med partnered with J&J. News
> Blog: AbbVie slams brakes on cancer drug trials after patient death. Report
And Finally... After several years of quiet among prescription sleep aids, Purdue Pharma has issued a wake up call to the category with an ad campaign featuring an adorably memorable anthropomorphic lightbulb. Item